{"id":16997,"date":"2024-12-06T16:45:16","date_gmt":"2024-12-06T08:45:16","guid":{"rendered":"https:\/\/flcube.com\/?p=16997"},"modified":"2024-12-06T16:45:20","modified_gmt":"2024-12-06T08:45:20","slug":"cambrex-partners-with-eli-lilly-to-enhance-clinical-development-for-biotech-collaborators","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=16997","title":{"rendered":"Cambrex Partners with Eli Lilly to Enhance Clinical Development for Biotech Collaborators"},"content":{"rendered":"\n

US-based contract development and manufacturing organization (CDMO) Cambrex has reached an agreement with Eli Lilly & Co., (NYSE: LLY<\/a>), to enhance the clinical development capabilities for the US giant’s biotech collaborators. This partnership aims to provide a comprehensive suite of services to support early-stage biotech innovation.<\/p>\n\n\n\n

Cambrex’s Role in Lilly Catalyze360-ExploR&D<\/strong>
Cambrex will collaborate with Lilly Catalyze360-ExploR&D, which is Eli Lilly’s early external innovation and collaboration arm. Through this collaboration, Cambrex will offer drug substance, drug product, analytical service labs, and R&D expertise to Lilly Catalyze360 biotech collaborators. The partnership focuses on providing a robust foundation for biotech companies to advance their drug development pipelines.<\/p>\n\n\n\n

Cambrex’s Longmont Facility and Services<\/strong>
Cambrex’s facility in Longmont is specialized in the early development of investigational new drugs. The facility covers the full spectrum from process development and drug substance manufacturing to formulation development and drug product manufacturing, including capacities for both non-GMP and cGMP production. Additionally, the site offers full analytical development and cGMP testing support, ensuring that biotech collaborators have access to the necessary resources for successful drug development.-Fineline Info & Tech<\/a><\/p>\n\n\n\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

US-based contract development and manufacturing organization (CDMO) Cambrex has reached an agreement with Eli Lilly…<\/p>\n","protected":false},"author":1,"featured_media":16999,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[2637,19,199,911],"class_list":["post-16997","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-cambrex","tag-cro-cmo-cdmo","tag-eli-lilly","tag-nyse-lly"],"yoast_head":"\nCambrex Partners with Eli Lilly to Enhance Clinical Development for Biotech Collaborators - Insight, China's Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"US-based contract development and manufacturing organization (CDMO) Cambrex has reached an agreement with Eli Lilly & Co., (NYSE: LLY), to enhance the clinical development capabilities for the US giant's biotech collaborators. This partnership aims to provide a comprehensive suite of services to support early-stage biotech innovation.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=16997\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cambrex Partners with Eli Lilly to Enhance Clinical Development for Biotech Collaborators\" \/>\n<meta property=\"og:description\" content=\"US-based contract development and manufacturing organization (CDMO) Cambrex has reached an agreement with Eli Lilly & Co., (NYSE: LLY), to enhance the clinical development capabilities for the US giant's biotech collaborators. This partnership aims to provide a comprehensive suite of services to support early-stage biotech innovation.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=16997\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China's Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2024-12-06T08:45:16+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-12-06T08:45:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/12\/0684.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"720\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=16997#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=16997\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Cambrex Partners with Eli Lilly to Enhance Clinical Development for Biotech Collaborators\",\"datePublished\":\"2024-12-06T08:45:16+00:00\",\"dateModified\":\"2024-12-06T08:45:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=16997\"},\"wordCount\":206,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=16997#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/12\\\/0684.png\",\"keywords\":[\"Cambrex\",\"CRO \\\/ CMO \\\/ CDMO\",\"Eli Lilly\",\"NYSE: LLY\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=16997#respond\"]}],\"copyrightYear\":\"2024\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=16997\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=16997\",\"name\":\"Cambrex Partners with Eli Lilly to Enhance Clinical Development for Biotech Collaborators - Insight, China's Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=16997#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=16997#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/12\\\/0684.png\",\"datePublished\":\"2024-12-06T08:45:16+00:00\",\"dateModified\":\"2024-12-06T08:45:20+00:00\",\"description\":\"US-based contract development and manufacturing organization (CDMO) Cambrex has reached an agreement with Eli Lilly & Co., (NYSE: LLY), to enhance the clinical development capabilities for the US giant's biotech collaborators. This partnership aims to provide a comprehensive suite of services to support early-stage biotech innovation.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=16997#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=16997\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=16997#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/12\\\/0684.png\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/12\\\/0684.png\",\"width\":1080,\"height\":720,\"caption\":\"Cambrex Partners with Eli Lilly to Enhance Clinical Development for Biotech Collaborators\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=16997#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cambrex Partners with Eli Lilly to Enhance Clinical Development for Biotech Collaborators\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Cambrex Partners with Eli Lilly to Enhance Clinical Development for Biotech Collaborators - Insight, China's Pharmaceutical Industry","description":"US-based contract development and manufacturing organization (CDMO) Cambrex has reached an agreement with Eli Lilly & Co., (NYSE: LLY), to enhance the clinical development capabilities for the US giant's biotech collaborators. This partnership aims to provide a comprehensive suite of services to support early-stage biotech innovation.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=16997","og_locale":"en_US","og_type":"article","og_title":"Cambrex Partners with Eli Lilly to Enhance Clinical Development for Biotech Collaborators","og_description":"US-based contract development and manufacturing organization (CDMO) Cambrex has reached an agreement with Eli Lilly & Co., (NYSE: LLY), to enhance the clinical development capabilities for the US giant's biotech collaborators. This partnership aims to provide a comprehensive suite of services to support early-stage biotech innovation.","og_url":"https:\/\/flcube.com\/?p=16997","og_site_name":"Insight, China's Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2024-12-06T08:45:16+00:00","article_modified_time":"2024-12-06T08:45:20+00:00","og_image":[{"width":1080,"height":720,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/12\/0684.png","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=16997#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=16997"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Cambrex Partners with Eli Lilly to Enhance Clinical Development for Biotech Collaborators","datePublished":"2024-12-06T08:45:16+00:00","dateModified":"2024-12-06T08:45:20+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=16997"},"wordCount":206,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=16997#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/12\/0684.png","keywords":["Cambrex","CRO \/ CMO \/ CDMO","Eli Lilly","NYSE: LLY"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=16997#respond"]}],"copyrightYear":"2024","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=16997","url":"https:\/\/flcube.com\/?p=16997","name":"Cambrex Partners with Eli Lilly to Enhance Clinical Development for Biotech Collaborators - Insight, China's Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=16997#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=16997#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/12\/0684.png","datePublished":"2024-12-06T08:45:16+00:00","dateModified":"2024-12-06T08:45:20+00:00","description":"US-based contract development and manufacturing organization (CDMO) Cambrex has reached an agreement with Eli Lilly & Co., (NYSE: LLY), to enhance the clinical development capabilities for the US giant's biotech collaborators. This partnership aims to provide a comprehensive suite of services to support early-stage biotech innovation.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=16997#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=16997"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=16997#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/12\/0684.png","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/12\/0684.png","width":1080,"height":720,"caption":"Cambrex Partners with Eli Lilly to Enhance Clinical Development for Biotech Collaborators"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=16997#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Cambrex Partners with Eli Lilly to Enhance Clinical Development for Biotech Collaborators"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/12\/0684.png","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/16997","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=16997"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/16997\/revisions"}],"predecessor-version":[{"id":17000,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/16997\/revisions\/17000"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/16999"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=16997"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=16997"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=16997"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}